Table 3 Poisson segmented regression models of the impact of treat-all on mean CD4 at ART initiation among PLHIV in China 1 January 2015 to 31 December 2019

0.990 (0.956–1.026)

0.585

0.973 (0.842–1.124)

0.709

0.998 (0.995–1.001)

0.196

0.997 (0.997–0.998)

 < 0.001

1.001 (0.968–1.036)

0.941

0.955 (0.822–1.109)

0.548

0.998 (0.995–1.001)

0.213

0.997 (0.996–0.998)

 < 0.001

0.932 (0.891–0.976)

0.003

1.124 (1.092–1.156)

 < 0.001

0.996 (0.995–0.996)

 < 0.001

1.000 (0.999–1.001)

0.567

1.015 (0.976–1.056)

0.447

0.932 (0.748–1.160)

0.526

1.001 (0.997–1.006)

0.553

0.999 (0.999–1.000)

0.081

1.002 (0.967–1.038)

0.926

0.881 (0.751–1.033)

0.118

1.001 (0.998–1.004)

0.553

0.998 (0.997–0.999)

 < 0.001

1.007 (0.944–1.074)

0.841

1.134 (0.915–1.404)

0.250

0.995 (0.991–0.999)

0.022

0.998 (0.997–1.000)

0.060

0.971 (0.876–1.076)

0.572

1.340 (0.921–1.949)

0.126

0.992 (0.985–0.998)

0.014

0.999 (0.998–1.000)

0.137

0.936 (0.852–1.027)

0.163

1.137 (0.866–1.493)

0.357

0.995 (0.989–1.000)

0.058

0.999 (0.998–1.000)

0.170

1.038 (0.994–1.084)

0.093

0.941 (0.837–1.057)

0.304

1.000 (0.997–1.002)

0.743

0.997 (0.996–0.998)

 < 0.001

1.024 (0.971–1.080)

0.380

0.908 (0.704–1.171)

0.458

1.001 (0.996–1.006)

0.727

0.998 (0.997–0.999)

0.001

1.033 (1.001–1.065)

0.041

0.916 (0.808–1.040)

0.175

1.002 (1.000–1.004)

0.042

0.999 (0.998–1.000)

0.113

1.080 (1.003–1.164)

0.042

0.805 (0.689–0.941)

0.007

1.002 (0.999–1.005)

0.126

0.995 (0.993–0.997)

 < 0.001

1.004 (0.939–1.074)

0.900

0.700 (0.475–1.031)

0.071

1.006 (0.998–1.014)

0.118

0.998 (0.996–0.999)

0.001

0.926 (0.867–0.989)

0.022

1.145 (0.875–1.499)

0.322

0.993 (0.988–0.998)

0.010

0.998 (0.997–0.999)

0.003

1.109 (0.971–1.268)

0.128

2.396 (1.589–3.614)

 < 0.001

0.982 (0.975–0.990)

 < 0.001

1.000 (0.998–1.003)

0.768